Lv31
230 积分 2021-06-22 加入
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
5小时前
待确认
Cardiovascular Risk Reduction With GLP-1 RA Drugs
21天前
已完结
Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum
21天前
已完结
Safety, tolerability, relative bioavailability, pharmacokinetics, and pharmacodynamics of single and multiple doses of the novel oral bofanglutide in healthy Chinese participants
1个月前
已完结
Once-Weekly Insulin Icodec: Safety Profile in Type 2 and Type 1 Diabetes Based on a Pooled Analysis of ONWARDS 1-6
1个月前
已完结
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update
1个月前
已完结
皖公网安备34019202002308
